Systemic and pulmonary haemodynamics were studied at rest in the supine and upright position, and during exercise in the sitting position at 75 Treatment resulted in a significant reduction of systemic systolic, diastolic, and mean pressures at rest in the supine position and during exercise, and of systolic pressures in the upright posture. Pulmonary systolic and mean pressures increased slightly at rest in the supine position and during exercise, and no changes occurred at rest in the upright position. The left ventricular filling pressure was unchanged at rest both in the supine and upright position; it increased slightly during exercise.
Systemic and pulmonary haemodynamics were studied at rest in the supine and upright position, and during exercise in the sitting position at 75 and 150 Watt, in 13 hypertensive men aged 5088-+7 years before and after 13 months treatment with oral oxprenolol (120 to 160 mg t.i.d.) supplemented by oral hydrallazine (50 to 75 mg t.i.d.) during the last 6 months. Pressures were recorded by means of catheters inserted percutaneously into the pulmonary and brachial artery; cardiac output was determined according to Fick. Treatment resulted in a significant reduction of systemic systolic, diastolic, and mean pressures at rest in the supine position and during exercise, and of systolic pressures in the upright posture. Pulmonary systolic and mean pressures increased slightly at rest in the supine position and during exercise, and no changes occurred at rest in the upright position. The left ventricular filling pressure was unchanged at rest both in the supine and upright position; it increased slightly during exercise.
The haemodynanmc changes by which systemic pressure was reduced were those typical of beta-adrenergic blockade: reduction of cardiac output resulting from a decrease of both heart rate and stroke volume, while the total systemic vascular resistance was unchanged at rest in the supine position but increased in the upright posture and during exercise. The A-V 02 difference increased remarkably.
This long-term observation again suggests that the acute haemnodynamic effects of an antihypertensive regimen can be modified during long-term application. It did not give evidence of a readjustment of the vascular resistance occurring, at least not in the upright position and during exercise, as has been suggestedfor long-term beta-adrenergic blockade.
Adrenergic beta-receptor blocking agents have increasingly been used in the treatment of hypertensive disease during the past years Gillam, 1966, 1969;  Dollery, Paterson, and Conolly, 1969; Johnsson et al., 1969; Werko, 1971; Eisalo et al., 1974; Bengtsson, 1974; Hansson and Werko, 1975, and others) . Their blood pressure lowering action is associated with a fall in cardiac output; the systemic vascular resistance is initially not consistently affected (Sannerstedt, 1974) , but may be reduced during prolonged treatment (Tarazi and Dustan, 1972) .
Advanced stages of hypertension are associated with low cardiac output and increased systemic Received 19 May 1976. vascular resistance (Lund-Johansen, 1967 (Ablad, 1963; Johnston, 1975; Zacest, 1975) . However, the pressure decrease activates the homeostatic mechanism of the baroreceptors, thus causing an increase in heart rate and cardiac output. This secondary effect has in the past limited the usefulness of vasodilators as antihypertensive agents.
Studies in both the experimental animal (Brunner, Hedwall, and Meier, 1967) and man (Sannerstedt et al., 1971) (Katila and Frick, 1970; Berglund and Hansson, 1971; Zacest, Gilmore, and Koch-Weser, 1972; Freeman and Knight, 1975) .
However, in spite of the evident rationale for combined beta-receptor blocking and vasodilator treatment, at least in certain stages of the hypertensive disease, information concerning the haemodynamic effects of such therapy is extremely scanty. There appears to be but a single study of its acute effects (Sannerstedt et al., 1971) 
Methods

General procedure
The patients were studied with identical techniques and under identical conditions before and after treatment with the combination of oxprenolol plus hydrallazine. The entire investigation programme comprised a complete clinical evaluation including blood and urine analysis, a chest x-ray film, spirometry, an exercise test with simultaneous electrocardiogram and blood pressure (cuff method) recording (Jacobsson et al., 1966) , inulin-and PAH-clearance, determination of blood volume and renin activity, and the haemodynamic investigation.
The antihypertensive treatment aimed at reaching blood pressure levels at rest below 140/90 mmHg when measured by the Riva Rocci method and during exercise at the highest load below 220/100 mmHg. Therapy was started within 4 weeks after the initial series of examinations with 40 mg t.i. (Forsberg, 1971 ) that the pulmonary artery diastolic pressure reflects the pulmonary wedge pressure provided there is no significant rise in pulmonary vascular resistance.
Blood and gas analyses The volume of expired air was measured in a gasometer, 02 and CO2 were determined according to Scholander (1947) , the 02 saturation and the haemoglobin concentration with a spectrophotometric method (Holmgren and Pernow, 1959 ) using a Beckman B photometer; pH, Po2, and Pco2 were determined with microelectrodes using Radiometer's PMH 72, lactic acid was determined enzymatically (Hohorst, 1963 ). Blood gas analyses were performed within 30 minutes after sampling. Methodological details, including the analytical accuracy, are given elsewhere (Koch, 1968) .
Statistical methods Current statistical methods were used for calculation of standard deviations (SD), mean differences (D), and t-analyses (Snedecor, 1967 Tables 2 and 3. The pretreatment average systemic blood pressure was 159/88 mmHg, mean 117 mmHg, at rest in the supine, and 165/100 mmHg, mean 125 mmHg, in the upright position; it rose to 248/113 mmHg, mean 160 mmHg, during exercise (W2). Treatment resulted in significantly lower blood pressure levels under all conditions, the effect being most pronounced during exercise and systolic pressures being most affected. Though the average diastolic and mean pressures during standing were about 10 per cent lower, this difference was just below the limit of statistical significance.
Blood pressures in the pulmonary circulation were within normal limits both before and after treatment; after treatment, however, they were slightly (P < 0 05 to P < 0-001) higher during exercise and at rest in the supine position. The effect was most pronounced during exercise.
Heart rate was significantly lower after treatment at rest in the upright position (170,' P < 0-05) and during exercise (18% and 24°', P<00001, at W1 and W2, respectively); it was on the average 8 beats lower in the supine position (0 1 >P < 005).
Both oxygen uptake (Vo2) and minute ventilation (VE) were lower in the upright position after treatment (P < 0'05), the minute ventilation was also lower during W, (P < 0-05).
Pretreatment cardiac output both at rest and during exercise was high (8&7 ±19 1/min at rest and 21P6 ±4 0 1/min at W2 corresponding to an oxygen uptake of 2 1/min) particularly when the patients' age is taken into account. Post-treatment cardiac outputs were significantly lower, the decrease ranging between 23 per cent at rest in the supine P < 0 01) and about 40 per cent in the erect VO2 ( position and during exercise (P < 0 001). This was partly the result of a similar decrease of the stroke volume ranging between 16 per cent at rest and 30 per cent during exercise (W2). The relative decrease in both cardiac output and stroke volume was most pronounced during exercise at the lower level.
Inversely to the changes of cardiac output the arterio-mixed venous oxygen difference was much higher after treatment, the increase ranging between 26 per cent (P < 0 01) at rest and 65 per cent (P < 0 001) during exercise.
Both before and after treatment total systemic vascular resistance was only slightly raised in comparison with normotensives; after treatment, it was not significantly changed at rest in the supine, but higher in the upright position (45%, P < 0 05) and during exercise (53 and 35%, P < 0*01, at W1 and W2, respectively). Post-treatment pulmonary vascular resistance was higher under all conditions.
There was a general tendency towards higher arteriai lactic acid concentrations after treatment; the increase being about 20 per cent during W2 (P<O01).
Discussion
Treatment with oxprenolol for an average duration of 13 months, supplemented by hydrallazine during the last 6 months, had a distinct antihypertensive effect both at rest and during exercise, inducing a fall in arterial mean pressures by 14 mmHg at rest and by 19 and 29 mmHg during exercise at loads W1 (oxygen uptake 1-2 +0-2 1/min) and W2 (oxygen uptake 2-0 ±0-2 1/min) respectively. In the erect posture the average systolic pressure was 20 mmHg lower after treatment; the decreases observed in mean and diastolic pressures were at borderline statistical significance.
The mode of antihypertensive action was similar at rest and during exercise: blood pressure was lowered by a reduction of cardiac output, while the systemic vascular resistance was mainly unchanged at rest in the supine position, but higher in the upright posture and during exercise. The relative reduction of cardiac output was most pronounced during work at the lower load (W1) at which it corresponded to 44 per cent of the pretreatment level. Both a decrease of stroke volume by maximally 30 per cent (W1) and of heart rate by maximally 24 per cent (W2) contributed to the reduction of cardiac output. These changes towards a more hypokinetic pattern of circulation were accompanied by a significant increase of the arterio-mixed venous oxygen (A-V 02) difference. During exercise at load W2 the A-V 02 difference rose from 94 to as much as 155 ml 02/1 blood. This type of haemodynamic adaptation is typical of that observed during the action of adrenergic beta-receptor blockers; it has also been reported for other agents interfering with sympathetic nervous activity, such as clonidine (Koch, 1971b) which mainly inhibits the sympathetic vasomotor centre, or the ganglion blocking agent guanethidine (Sannerstedt and Conway, 1970) .
Haemodynamic observations after prolonged treatment with adrenergic beta blocker agents are, however, scanty and mainly confined to resting conditions and relatively short periods; in only one study did duration of treatment apparently exceed 12 months (Tarazi and Dustan, 1972) . While all studies have shown the typical reduction of heart rate, blood pressure, stroke volume, and cardiac output and the increase of the A-V 02 difference (Frohlich et al., 1968; Eisalo, Luomanmaki, and Heikkila, 1969; Taylor et al., 1970; Majid et al., 1970; Sannerstedt et al., 1972; Tarazi and Dustan, 1972; Hansson et al., 1974) , the results are contradictory with respect to the effect on systemic vascular resistance. Vascular resistance regularly increases in the acute experiment and in the early stage of treatment with a beta-receptor blocking agent (Sannerstedt, 1974) . While earlier observations indicated that this rise in resistance persisted during long-term treatment (Frohlich et al., 1968) , recent findings suggest that it may return to initial or even lower levels during prolonged treatment in spite of sustained reduction of blood pressure and cardiac output (Tarazi and Dustan, 1972; Hansson et al., 1974) . Resetting of the baroreceptors in response to chronic reduction of cardiac output (Tarazi and Dustan, 1972) and/or adaptation changes in the blood vessel calibre (Brunner, 1974) have been thought to be responsible for this change in vascular resistance. In the present study, systemic vascular resistance increased in 9 and decreased in 4 patients at rest in the recumbent position, but it increased in all patients in the upright posture and during exercise. Despite a drastic reduction of cardiac output and a duration of treatment exceeding one year, and in spite of the additional use of the vasodilator hydrallazine, the results of the present study thus do not give evidence of such a readjustment of the vascular resistance occurring, at least not as far as conditions at rest in the erect posture and during exercise are concerned.
The patients included in the present study corresponded mainly to stage 1 to 2 hypertension according to the W.H. O. classification (1959) ; roughly 50 per cent of them were only moderately hypertensive and their pretreatment cardiac outputs showed a surprisingly hyperkinetic pattern of circulation: 8-7 ±1-7 and 21-6 ±4 0 1/min corresponding to cardiac indices of 4 0 ±0 9 and 10'7 ± 2-0 1/min x m2 at rest and during W2, respectively. Correspondingly, their A-V 02 differences were low, and the systemic vascular resistance was only moderately raised. This degree of hyperdynamic circulation is unusual for hypertensives of this age group and has probably largely contributed to the pronounced effects of treatment observed on cardiac output, the A-V 02 difference and on the calculated vascular resistance. It is established that the cardiac output lowering effect of beta-receptor blockade is most pronounced in hyperkinetic states (Sannerstedt, 1974) .
However, the degree of reduction of cardiac output in the present study is still more surprising in view of the additional treatment with the peripheral vasodilator hydrallazine. From acute experiments (Brunner et al., 1967; Sannerstedt et al., 1971 Sannerstedt et al., , 1972 one should expect an attenuation or reversal of the cardiac output reducing effect and a group.bmj.com on April 30, 2017 -Published by http://heart.bmj.com/ Downloaded from decrease of vascular resistance. Using a dye dilution technique, Sannerstedt (1974) actually found this trend of haemodynamic readjustment after addition of hydrallazine to alprenolol in 3 hypertensive patients at rest; treatment with alprenolol had lasted for one month and combined treatment with additional hydrallazine for another 2 to 5 months. The results obtained in the present study at rest in the supine position are consistent with these observations, but the data obtained in the upright posture and particularly during exercise suggest that the vasodilator haemodynamic action of hydrallazine under these conditions is highly, if not entirely, overshadowed by that of the beta-receptor blocking agent. This simply implies that the betareceptor blockade obtained with the dose of oxprenolol was efficient enough not only to control the hyperdynamic circulation of these patients but also to inhibit the hydrallazine-induced baroreflex mechanism.
Our knowledge of the effect of antihypertensive drugs on the pulmonary circulation is still more limited. It is generally agreed that alpha-and betareceptor mediated vasomotor effects do not play a substantial role in the regulation of the pulmonary circulation and that pressure changes in the systemic arterial circulation have very little effect on the low pressure system of the pulmonary circulation (Gauer, 1972) . In the present study pulmonary arterial pressures rose slightly at rest in the recumbent position and during exercise, and were unchanged in the upright position. Because of the substantial reduction of cardiac output, however, the calculated pulmonary vascular resistance was higher in all instances. These findings are at variance with the observation of insignificantly changed pulmonary pressures and resistances at rest and during moderate exercise after a 12-week oral administration of oxprenolol in the series of Taylor et al. (1970) . However, this discrepancy might be entirely the result of the small number of patients (6) in the latter series. Clonidine (Koch, 1971b) , which apparently inhibits the sympathetic vasomotor centre, and AH 5158, a combined alpha-and beta-receptor blocking agent (Koch, 1976) , lacked the pressure raising effect on the pulmonary circulation at least in the acute experiment.
The pulmonary artery diastolic pressure has been shown (Forsberg, 1971) to reflect pulmonary wedge and thus left ventricular filling pressures in the absence of significant increases in pulmonary vascular resistance. Though the use of left ventricular filling pressure as a method of evaluating myocardial contractility is crude and insensitive, the absence of any pressure rise at rest both in the recumbent and the erect posture suggests that oxprenolol, at least in the combination with hydrallazine lacks significant negative inotropic effects at rest; but this effect is measurable during work and apparently increases with the work load. An increase of exercise pulmonary wedge pressure of a similar magnitude was observed after oral oxprenolol by Taylor et al. (1970) . In this series, however, the effect of oxprenolol on pulmonary artery pressures and resistances and on pulmonary wedge pressure was less pronounced than that of propranolol. This supports the concept that oxprenolol does possess direct cardiostimulating properties besides its beta-receptor blocking action. The finding of an increased left ventricular filling pressure during long-term oral oxprenolol treatment during exercise but not at rest in the present study is consistent with this concept since the direct cardiostimulating action is known to be most effective at rest.
